Age (years) (mean (range)) | 38.6 (23–73) |
Sex: men/women (n (%)) | 27 (57.5)/20 (42.5) |
Admission Hunt and Hess grade (n (%)) | |
| 22 (47) |
| 25 (53) |
Admission Fisher grade (n (%)) | |
| 6 (13) |
| 22 (47) |
| 19 (40) |
Intracranial hemorrhage at admission (n (%)) | |
| 46 (98) |
| 16 (34) |
| 2 (4) |
| 1 (2) |
Location of 56 treated aneurysms (n (%)) | |
| 21 (38) |
| 8 (14) |
| 7 (13) |
| 6 (11) |
| 5 (9) |
| 4 (7) |
| 3 (5) |
| 1 (2) |
| 1 (2) |
Aneurysm size (mean (range)) | |
| 4.7 (1.7–12.1) |
| 3.2 (1.5–7.1) |
Incidental associated aneurysms | |
| 11 |
| 9 |
| 13 |
Ventriculostomy (n (%)) | 38/47 (80) |
| 35 (92) |
| 3 (8) |
Ventriculoperitoneal shunt (n (%)) | 4/47 (9) |
| 2 (4) |
| 2 (4) |
Antiplatelet therapy (n (%)) | |
| 29 (62) |
| 11 (23) |
| 7 (15) |
Embolization technique in treated aneurysms (n (%)) | |
Single stent embolization | 39 (70) |
| 20 |
Coiling | 3 |
No coiling | 17 |
| 19 |
Trans stent coiling | 8 |
Half T | 1 |
Jailing coiling | 5 |
Waffle cone technique | 3 |
pCONus | 2 |
Dual stent embolization | 17 (30) |
| 12 |
Y stenting | 6 |
X stenting | 3 |
T stenting | 3 |
| 5 |
Immediate occlusion grade (n (%)) | |
| 31/56 (55) |
mRCCI | 22 (71) |
mRCCII | 7 (23) |
mRCCIIIa | 2 (6) |
| 3/56 (5) |
mRCCIIIa | 3 (100) |
| 22/56 (40) |
SMART grade 3 | 19 (27) |
SMART grade 2 | 11 (50) |
SMART grade 1 | 5 (23) |
Intraprocedure thromboembolic complications (n (%)) | |
| 4 (9) |
Clinical status at 90 day follow-up (n (%)) | |
| 27 (57) |
| 13 (28) |
| 2 (4) |
| 3 (6) |
| 2 (4) |
Occlusion grade at 9–12 month follow-up (45 surviving patients , 54 treated aneurysms) (n (%)) | |
| 29/54 (54) |
mRCC I | 26 (90) |
mRCCIIIa | 3 (10) |
| 3/54 (6) |
mRCCI | 2 (66) |
mRCCIIIa | 1 (33) |
| 22/54 (40) |
SMART grade 4 | 19 (86) |
SMART grade 3 | 3 (14) |
mRCC, modified 4 point Raymond–Roy Scale; mRS, modified Rankin Scale; SMART, simple measurement of aneurysm residual after treatment.